China Shineway Pharma schedules board meeting on interim results, dividend decisionPUBT·Aug 17 at 03:32 AM02877-1.59%
Severed Apple Ties and a Dividend Surge: How Hong Kong's Fringe Stocks Are Navigating 2026Global Report·Jul 29 at 04:18 AM080030.00%03816+5.15%
Macro Signals Testing the Hong Kong Market: Pricing From Real Estate to CyclicalsGlobal Report·Jul 21 at 04:13 AM02877-1.59%09696+11.74%
The Island of Misfit Stocks: From Elon's Giga Press to Real Estate DefaultsGlobal Report·Jul 17 at 04:12 AM02877-1.59%01685-2.17%
Kingsoft Gets the Boot While Instant Noodles and Infrastructure Quietly Print CashGlobal Report·Jul 7 at 05:38 AM03888+2.16%03996+0.47%
China Shineway Pharma Sets 2026 AGM to Approve Results and Share Issuance MandateTip Ranks·Apr 23 at 05:12 AM02877-1.59%
China Shineway Pharmaceutical Declares First Interim Dividend for Fiscal 2026Tip Ranks·Mar 26 at 11:55 PM159929-3.34%512290-3.77%
Shineway Profit Rises Despite Revenue Slump as TCM Sector ResetsTip Ranks·Mar 26 at 11:09 PM512290-3.77%159992-4.49%
China Shineway Pharmaceutical Group Limited (2877) Receives a Buy from Guoyuan Securities (HK)Tip Ranks·Dec 18, 2025 at 11:05 PM02877-1.59%
Zhitong Hong Kong Stock Investment Diary | September 9Zhitong·Sep 8, 2025 at 11:01 AM01209+1.33%601857+1.91%
SHINEWAY PHARM released its interim results, with a profit of 615 million yuan, a year-on-year decrease of 1.89%Zhitong·Aug 26, 2025 at 11:07 PM02877-1.59%
Zhitong Hong Kong Stock Investment Log | August 27Zhitong·Aug 26, 2025 at 11:01 AM06911-1.74%002480.00%
SHINEWAY PHARM: Wang Guihua has been appointed as a member of the Nomination CommitteeZhitong·Jun 9, 2025 at 11:22 PM02877-1.59%
